Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drugs, Chinese Herbal | 3 | 2017 | 142 | 0.660 |
Why?
|
| Lipocalins | 2 | 2015 | 162 | 0.580 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2017 | 616 | 0.470 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 252 | 0.460 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 255 | 0.440 |
Why?
|
| Osteosarcoma | 2 | 2017 | 909 | 0.400 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 2423 | 0.400 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1352 | 0.370 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2021 | 93 | 0.360 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 5337 | 0.350 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 752 | 0.350 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2822 | 0.340 |
Why?
|
| Bone Neoplasms | 2 | 2017 | 2567 | 0.260 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2021 | 636 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4520 | 0.210 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13648 | 0.190 |
Why?
|
| Catechin | 1 | 2021 | 69 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 3608 | 0.180 |
Why?
|
| Seeds | 1 | 2021 | 124 | 0.180 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2020 | 62 | 0.170 |
Why?
|
| Triazoles | 2 | 2017 | 897 | 0.170 |
Why?
|
| NF-kappa B | 3 | 2021 | 2485 | 0.160 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 269 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 6364 | 0.150 |
Why?
|
| Neoplasms | 3 | 2021 | 22340 | 0.140 |
Why?
|
| Scutellaria baicalensis | 1 | 2017 | 2 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2021 | 496 | 0.140 |
Why?
|
| Argon | 1 | 2017 | 36 | 0.140 |
Why?
|
| Plasma Gases | 1 | 2017 | 11 | 0.140 |
Why?
|
| Flavanones | 1 | 2017 | 75 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 1333 | 0.130 |
Why?
|
| Apoptosis | 5 | 2021 | 9514 | 0.130 |
Why?
|
| Horses | 1 | 2016 | 293 | 0.120 |
Why?
|
| Swine | 2 | 2016 | 5988 | 0.120 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 17075 | 0.120 |
Why?
|
| Phytotherapy | 1 | 2017 | 298 | 0.120 |
Why?
|
| Plant Proteins | 1 | 2017 | 374 | 0.120 |
Why?
|
| Interleukins | 1 | 2019 | 791 | 0.110 |
Why?
|
| Myosin Heavy Chains | 1 | 2016 | 402 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2019 | 23601 | 0.110 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2013 | 50 | 0.110 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2013 | 127 | 0.100 |
Why?
|
| Binding Sites | 1 | 2021 | 6001 | 0.100 |
Why?
|
| Animals | 16 | 2023 | 168764 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2021 | 1393 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 1668 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2015 | 352 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2016 | 2034 | 0.090 |
Why?
|
| Muscles | 1 | 2016 | 1578 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1808 | 0.090 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 9525 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13451 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1921 | 0.090 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 295 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 4958 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3141 | 0.080 |
Why?
|
| Neutrophils | 1 | 2022 | 3776 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2021 | 3222 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 8611 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2015 | 2230 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2021 | 3618 | 0.080 |
Why?
|
| Mice | 8 | 2023 | 81819 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4893 | 0.080 |
Why?
|
| Sepsis | 1 | 2022 | 2606 | 0.070 |
Why?
|
| Piperazines | 1 | 2017 | 2549 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2892 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8041 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 431 | 0.060 |
Why?
|
| Mitochondria | 1 | 2017 | 3673 | 0.050 |
Why?
|
| Spectrin | 1 | 2023 | 174 | 0.050 |
Why?
|
| Complement C1q | 1 | 2022 | 82 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3819 | 0.050 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2023 | 379 | 0.050 |
Why?
|
| Carbonic Anhydrase I | 1 | 2021 | 4 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2015 | 6255 | 0.050 |
Why?
|
| Carbonic Anhydrase II | 1 | 2021 | 21 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 3047 | 0.050 |
Why?
|
| Carbonic Anhydrases | 1 | 2021 | 107 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2020 | 12131 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11888 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2021 | 580 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 720 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 399 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 498 | 0.040 |
Why?
|
| Humans | 13 | 2023 | 765968 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7562 | 0.040 |
Why?
|
| Germination | 1 | 2017 | 17 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 1885 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 1526 | 0.030 |
Why?
|
| Phenols | 1 | 2021 | 522 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2021 | 1752 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2021 | 1884 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2017 | 94 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16047 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1167 | 0.030 |
Why?
|
| Breeding | 1 | 2016 | 49 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3051 | 0.030 |
Why?
|
| Drug Design | 1 | 2021 | 1042 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1599 | 0.030 |
Why?
|
| Protein Transport | 1 | 2021 | 1939 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10429 | 0.030 |
Why?
|
| Rats | 2 | 2021 | 23707 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 21056 | 0.030 |
Why?
|
| Catalepsy | 1 | 2013 | 31 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6113 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 61 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 523 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 2002 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2013 | 364 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 4137 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 577 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2021 | 1064 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1510 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 842 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 366 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 924 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2021 | 2867 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2015 | 1160 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 619 | 0.020 |
Why?
|
| Cell Movement | 1 | 2023 | 5194 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2016 | 1206 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2016 | 1997 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 2745 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2015 | 2171 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4348 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10729 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 1467 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4642 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2721 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4335 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5881 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1748 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3750 | 0.020 |
Why?
|
| Genome | 1 | 2016 | 1753 | 0.020 |
Why?
|
| Ligands | 1 | 2015 | 3273 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 20124 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2140 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2832 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15543 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9550 | 0.020 |
Why?
|
| Male | 4 | 2021 | 363698 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5379 | 0.020 |
Why?
|
| Epilepsy | 1 | 2021 | 3320 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4260 | 0.010 |
Why?
|
| Motor Activity | 1 | 2013 | 2704 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18293 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4462 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10850 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12768 | 0.010 |
Why?
|
| Female | 3 | 2023 | 396112 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30198 | 0.010 |
Why?
|
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_